Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chubb
Accenture
Chinese Patent Office
Julphar
Cerilliant
Harvard Business School
McKesson
Daiichi Sankyo

Generated: December 18, 2018

DrugPatentWatch Database Preview

VANTIN Drug Profile

« Back to Dashboard

Which patents cover Vantin, and when can generic versions of Vantin launch?

Vantin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in VANTIN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.

Summary for VANTIN
Drug patent expirations by year for VANTIN
Synonyms for VANTIN
(+-)-1-Hydroxyethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), isopropyl carbonate (ester)
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
(E)-Cefpodoxime Proxetil
(RS)-1-((Isopropoxycarbonyl)oxy)ethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
(RS)1(isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3methoxymethyl-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate
1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
239C814
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester,(6R-(6-alpha,7-beta(Z)))-
87239-81-4
947692-13-9
AB01209734-01
AB01563099_01
AC1O426I
AC1O6HBL
AK322023
AKOS015994692
AN-7622
Antibiotic CS 807
API0001908
Banan
BRD-A87387433-001-01-9
C08115
C21H27N5O9S2
CAS-87239-81-4
CC0150
CCG-213498
CCG-221250
Cefodox
Cefoprox
cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester
cefpodoxime proxetil
Cefpodoxime proxetil (JP17/USP)
Cefpodoxime proxetil [USAN:JAN]
Cefpodoxime proxetil [USAN:USP:JAN]
Cefpodoxime Proxetil EP Impurity D
CEFPODOXIME PROXETIL, VANTIN
Cefpodoximeproxetil
Cefpodoximproxetil
cephalosporin 807
Cephpodoxime Proxetil
Cepodem
CHEBI:3505
CHEBI:94455
CHEMBL1201016
CPD000469193
CS 807
CS-807
D00920
Doxef
DR003263
DSSTox_CID_2766
DSSTox_GSID_22766
DSSTox_RID_76722
DTXSID1022766
HE399637
HMS2093B08
KS-1149
LS-150022
LTINZAODLRIQIX-FBXRGJNPSA-N
MFCD00865088
MLS001401428
MolPort-003-845-692
NCGC00164598-01
NCGC00183131-01
NSC-759161
NSC759161
Orelox
Otreon
Pharmakon1600-01505637
Podomexef
RU-51807
SAM001246674
SBI-0206821.P001
SCHEMBL27071
SCHEMBL379709
Simplicef
Simplicef [Veterinary]
SMR000469193
SR-05000001937
SR-05000001937-1
Tox21_113377
Tox21_113428
U 76252
U-76,252
U-76252
Xtum-O

US Patents and Regulatory Information for VANTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn VANTIN cefpodoxime proxetil FOR SUSPENSION;ORAL 050675-001 Aug 7, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn VANTIN cefpodoxime proxetil TABLET;ORAL 050674-002 Aug 7, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn VANTIN cefpodoxime proxetil FOR SUSPENSION;ORAL 050675-002 Aug 7, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn VANTIN cefpodoxime proxetil TABLET;ORAL 050674-001 Aug 7, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chubb
Accenture
Chinese Patent Office
Julphar
Cerilliant
Harvard Business School
McKesson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.